PEPTOLOGY.PH

PEPTOLOGY LABS RESEARCH SUBJECTS

📘 RESEARCH THREAD: RETATRUTIDE

📘 RESEARCH BRIEF
Retatrutide (Triple Agonist)
Public Education & Dosing Logic Overview

🔬 WHAT IS RETATRUTIDE (IN SIMPLE TERMS)Retatrutide is a next-generation weight-loss and metabolic research drug.It works on three hormone pathways at the same time:● GLP-1 → reduces hunger 🍽️
● GIP → improves insulin response 🩸
● Glucagon → increases energy use (burns more fuel) 🔥> Think of it as:
> “Eat less + absorb better + burn more”This is why retatrutide causes
very large weight loss
in clinical trials.

📊 WHAT PHASE 3 RESEARCH SHOWEDMajor clinical trials found:● Average weight loss: ~25–30% of body weight
● Effects comparable to bariatric surgery in some patients
● Strong improvements in:
~ Blood sugar
~ Blood pressure
~ Joint pain (especially knees)⚠️ But also found:● Higher doses more side effects
● New nerve-related sensations
(tingling, burning, odd skin feelings)
● Some people stopped treatment because weight loss was “too fast”> Conclusion:
> Retatrutide is very powerful
> Not something to rush.

❗ WHY “USUAL DOSING CHARTS” ARE MISLEADINGMany charts online show:0.5 → 1 → 2 → 4 → 8 → 12 mg
every few weeks, automatically🚫 This is NOT how real science works.Problems with these charts:● Ignore drug half-life
● Ignore leftover drug from previous injections
● Ignore body size (BMI)
● Ignore nervous system side effects
● Assume “higher is always better”> Real biology does NOT work on calendars.
> It works on how long drugs stay active in the body.

⏳ THE KEY SCIENCE RULE (VERY IMPORTANT)Retatrutide stays active in the body for
many days.This means:● Each dose stacks on the previous one
● Full effect appears after ~4–5 weeks
● Increasing dose too fast = overdosing without realizing it> Simple rule:
> Never judge or increase a dose
> before the body fully adapts.

📐 UNIVERSAL DOSING RULES (EASY VERSION)These rules apply to ALL people
and ALL vial sizes.1️⃣ Start low
The body needs time to “learn” the drug2️⃣ Stay on the same dose for at least 4 weeks
Allows steady drug levels3️⃣ Increase only if needed
If weight is already dropping → do NOT rush4️⃣ Higher dose ≠ better
Higher dose = more side effects + nerve symptoms5️⃣ Strange nerve sensations = STOP increasing
Tingling • burning • weird skin feelings 🚨

🧠 WHY BODY SIZE (BMI) MATTERSClinical trials mainly used people with
high body weight.This means:● Larger bodies may need more drug
● Smaller bodies may need much lessGiving the same dose to everyone is a mistake.> Think of it like alcohol 🍺
> One bottle affects a small person
> more than a big person.

🧪 UNIVERSAL SAMPLE DOSING GUIDE (RESEARCH MODEL)⚠️ This is a conceptual research framework
NOT instructions • NOT prescriptionsThe goal is to match dose strength to body needs.🔹 Tier 1 – Signal / Introduction Phase
~ ~0.5–1 mg weekly
~ Goal: safe introduction
~ Allow the body to recognize the drug🔹 Tier 2 – Appetite & Metabolic Control
~ ~2–4 mg weekly
~ Hunger reduction + glucose control🔹 Tier 3 – Strong Fat Loss Phase
~ ~6–8 mg weekly
~ Consistent, meaningful weight loss🔹 Tier 4 – High-Intensity / Bariatric-Level
~ ~9–12 mg weekly
~ Severe obesity / high medical risk
~ NOT for everyoneMany people should NEVER go beyond Tier 2 or Tier 3

🔁 TRANSITIONING FROM TIRZEPATIDE TO RETATRUTIDEThis is where many people make mistakes.Tirzepatide stays in the body for
days to weeks.Even after stopping:● ~35–40% remains after 7 days
● ~25% after ~10 days
● ~12% after ~15 daysIf retatrutide is added too soon:● Drugs stack
● Side effects increase
● Nervous system overload occurs> Transition rule:
> Do NOT treat the switch as instant.

🔁 SAFE TRANSITION LOGIC (EDUCATIONAL MODEL)When moving from tirzepatide → retatrutide:1️⃣ Allow tirzepatide levels to decline
2️⃣ Start retatrutide at Tier 1 doses
3️⃣ Hold longer at low doses
4️⃣ Avoid overlapping high doses> fade out → fade in
> swap and stack

🚨 WHEN NOT TO INCREASE DOSE❌ Do NOT increase if:● Weight is already dropping fast
● Nausea or vomiting is frequent
● Heart rate feels persistently high
● Tingling / burning / nerve sensations appear
● Fatigue or weakness becomes excessive> These are signs the body is overloaded.

✅ WHAT RESPONSIBLE USE LOOKS LIKE✔ Responsible, research-aligned use:● Slow dose changes
● Predictable weight loss
● Minimal side effects
● Ability to stop or reduce safely❌ Irresponsible use:Copy-pasting internet charts
Rushing to the highest mg
Ignoring body signals
Treating mg like a competition

📌 FINAL PUBLIC MESSAGERetatrutide is not
“just a stronger GLP-1”.It is a powerful metabolic tool
that rewards:● time ⏳
● patience 🧠
● lower starting doses
● respect for nervous system signalsThis is what separates science from guessing> Slow is not weak.
> Slow is how you stay safe.

📘 RESEARCH THREAD: RETATRUTIDE

📘 RESEARCH BRIEF
Retatrutide (Triple Agonist)
Public Education & Dosing Logic Overview

🔬 🔥 “Plateau sa Tirz” (profiling + decision guide)May common story sa GC:● 3 months sa 5mg
● ~2 months walang bawas ang weight kahit “controlled naman”
● Nag-updose to 7.5mg
● Appetite suppression hindi na consistent> If ikaw ito, basahin muna bago sabihing “wala na effect”.
━━━━━━━━━━━━━━━━━
1) Plateau at 5mg or 7.5mg ≠ immune ka naMost of the time, hindi ka desensitized.
Mas madalas ito dahil:
● Mid-dose pa lang for your body
● Weight loss is step-by-step, hindi straight line
● Appetite suppression can fade first kahit gumagana pa rin ang gamotImportant: appetite ≠ total metabolic effect.
━━━━━━━━━━━━━━━━━
2) May dose ladder ang tirzepatideHindi ito gawa-gawa ng seller.
Clinical trials + FDA label support ito.Typical ladder:
2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg (max)Meaning:
● 5mg at 7.5mg = mid-ladder, hindi end game
● Marami hindi “fully on” ang effect until 10mg pataas3) Evidence-based moveSa obesity trials, may clear dose-response:
higher dose → bigger average weight loss.So kung stuck ka sa 5mg/7.5mg:
✅ Next step if tolerated
❌ Hindi agad stop o “wala na effect”4) Research peptides vs evidence-based medsIf research peptide:
● Kulang sa human trials
● Walang standard dosing
● Hindi sure ang appetite pathwayExample: AOD-9604
– May human studies
– ❌ Not effective for weight lossSS-31 / MOTS-C / AOD = support only
❌ Not main appetite driver5) About “Cagri” (cagrilintide)Different pathway (amylin).
May weight mgmt studies pero investigational pa.Think:
● Possible support
● ❌ Not automatic fix sa plateau6) “Reta is stronger?” contextRetatrutide (Reta) has human phase 2 data:
very large avg weight loss at higher doses.
Phase 3 ongoing.So if choosing next-level:
✅ Real human trial evidence
❌ Random “research-only” peptides7) Quick self-check bago sabihing “wala na effect”● Same dose, same day weekly?
● Missed / late injections?
● Weight = weekly average, not daily swings?
● Protein ok? Sleep ok? Steps ok?
● Any GI or gallbladder symptoms?🔥 Bottom lineStaying low dose for months is not always “normal”.
Most often it means stuck mid-ladder.That’s why the clinical dose ladder exists.

SOON